Search results
Earnings call: AIM ImmunoTech highlights Q1 2024 progress on cancer trials By Investing.com
Investing.com· 4 hours agoAIM ImmunoTech (NYSE:AIM) Inc. (NYSE American: AIM) provided an optimistic update during its first...
Flowers Foods posts slight miss in Q1 earnings, revenue in line By Investing.com
Investing.com· 39 minutes agoThe company's net income also saw a marginal increase of 3.3% to $73.0 million, primarily due to...
Earnings call: Eyenovia reports Q1 2024 results, focuses on product pipeline By Investing.com
Investing.com· 6 hours agoEyenovia, Inc. (NASDAQ:EYEN), a biopharmaceutical company specializing in ophthalmic diseases,...
Earnings call: Bakkt projects growth with Q1 revenue up 33% By Investing.com
Investing.com· 6 hours agoThe company's CEO, Andy Main, outlined three strategic priorities during the earnings call:...
Earnings call: Fluent reports Q1 revenue decline but sees growth in new markets By Investing.com
Investing.com· 7 hours agoFluent Inc. (NASDAQ:FLNT) reported a decline in revenue for the first quarter of 2024, with a 14.6%...
Earnings call: Xunlei sees revenue growth in Q1 despite challenges By Investing.com
Investing.com· 4 hours agoIn the first quarter of 2024, Xunlei (ticker: XNET) reported a revenue of $80.4 million, marking a...
Netflix advertising is booming: More than 40 million users are now on its ad-supported tier
Fast Company Magazine· 1 hour agoNetflix was late to the ad-supported side of the subscription streaming world, but it is quickly...
Earnings call: Siemens affirms resilience with robust Q2 results amid challenges By Investing.com
Investing.com· 4 hours agoSiemens AG (OTC:SIEGY (BA:SIEGY)) has reported a solid performance for the second quarter,...
Earnings call: Movano Health Q1 2024 earnings focus on Evie Ring, FDA progress By Investing.com
Investing.com· 8 hours agoMovano Health (Ticker: MOVE) reported its first-quarter earnings for 2024, emphasizing advancements...
Jim Cramer's top 10 things to watch in the stock market Thursday
CNBC· 8 hours agoThe market moved further into overbought territory, according to my trusted momentum indicator, the...